washout period

14 papers; 12 titles.

Back to keywords

Conference ×	Year ×	Title ×	Authors	Extras	Pages
WUSS	2025	FDA says, Do the Allowable Total Difference Zone: A Method Comparison using the ATDzone SAS Macro	Jesse Albert Canchola, Natasha Oza	source	22
WUSS	2025	Inter-reader Variability and Reader Weighting in Diagnostic Accuracy Studies using the SAS System	Jesse Albert Canchola, Monica Vasquez, Payam Ahmadi	source	22
PharmaSUG	2025	A Case Study on Visualization Methods in R	Margaret Huang, Chunting Zheng, Lei Zhao, Todd Case	source	15
PHUSE US	2025	Clearing Up Confusion with Reference Dates	Swathi Kotla, Dana Booth	source poster source	5
PharmaSUG CN	2017	How to define Treatment Emergent Adverse Event (TEAE) in crossover clinical trials	Mengya Yin, Wen Tan		6
PharmaSUG	2017	How to define Treatment Emergent Adverse Event (TEAE) in crossover clinical trials	Mengya Yin, Wen Tan	source	6
PharmaSUG	2015	TEAE: Did I flag it right?	Arun Raj Vidhyadharan, Sunil Mohan Jairath	source	5
PHUSE EU	2009	Graphical Reporting of Clinical Trial Data with SAS ODS Graphics	Hans-Rainer Pauli	source	47
PharmaSUG	2009	Clinical Trial Reporting Using SAS/GRAPH SG Procedures	Susan L. Schwartz		21
SGF	2009	Clinical Trial Reporting Using SAS/GRAPH SG Procedures	Susan L. Schwartz	source	21
PharmaSUG	2006	Estimate Carryover Effect in Clinical Trial Crossover Designs	David Shen, Zaizai Lu		7
SUGI	1999	Cross Crossover Studies Off Your List	Pippa M. Simpson, Robert M. Hamer, Shelly Y. Lensing	source	7
NESUG	1994	Statistical Methods for Assessing the Safety of Products Evaluated in Human Clinical Trials	John Sourby		8
SUGI	1990	The Analysis of Data from 2 X 2 Crossover Trials with Baseline Measurements	Joe DiGennaro, William C. Huster	source	6

Back to keywords